Since the beginning of the year, recession fears have gripped the stock market. Bank of America's Global Fund Manager survey for August found that 58% of investors expect a downturn in the coming 12 months.
Investors foresee consumers tightening their purse strings because of the persistently high inflation. However, medicine is something that consumers cannot forgo spending on to save money. Pharmaceutical companies are expected to benefit from the rapidly aging population and the rising chronic diseases.
